ID: h-d4f71a6b
Hypothesis
Transglutaminase-2 Cross-Linking Inhibition Strategy
Transglutaminase-2 creates covalent cross-links between lysine and glutamine residues shared across tau, α-synuclein, and TDP-43, stabilizing heterologous aggregates.
EvidencePending (0%)📖 9 cit🗣 3 debates✓ 3 support✗ 3 oppose
✓ All Quality Gates Passed
🧪 Overview
Transglutaminase-2 creates covalent cross-links between lysine and glutamine residues shared across tau, α-synuclein, and TDP-43, stabilizing heterologous aggregates. Selective TG2 inhibitors targeting the cross-seeding-specific substrate sites could disrupt mixed aggregate formation while preserving physiological TG2 functions.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
graph TD
A["""Neuroinflammation<br/>& Calcium Dysregulation"""] -->|"Ca2+ Influx"| B["TG2 Activation<br/>(Transglutaminase-2)"]
B -->|"Isopeptide Bond<br/>Formation"| C["Tau Cross-Linking<br/>& Aggregation"]
B -->|"Protein Cross-Linking"| D["Abeta Oligomer<br/>Stabilization"]
B -->|"ECM Cross-Linking"| E["BBB Disruption<br/>& Matrix Stiffening"]
B -->|"NF-kappaB Activation"| F["Pro-inflammatory<br/>Cytokine Cascade"]
C --> G["Neurofibrillary<br/>Tangle Formation"]
D --> H["Amyloid Plaque<br/>Stabilization"]
E --> I["Peripheral Immune<br/>Cell Infiltration"]
F --> J["Chronic<br/>Neuroinflammation"]
G --> K["Neuronal Death<br/>& Cognitive Decline"]
H --> K
I --> J
J --> K
L["""TG2 Inhibitor<br/>Therapy"""] -->|"Selective Active-Site<br/>Blockade"| M["TG2 Cross-Linking<br/>Inhibition"]
M -->|"Reduced Tau<br/>Cross-Linking"| N["Prevented Tangle<br/>Formation"]
M -->|"Reduced Abeta<br/>Stabilization"| O["Enhanced Abeta<br/>Clearance"]
M -->|"Preserved BBB<br/>Integrity"| P["Reduced Immune<br/>Infiltration"]
M -->|"Suppressed NF-kappaB"| Q["Reduced<br/>Neuroinflammation"]
N --> R["Neuroprotection &<br/>Cognitive Preservation"]
O --> R
P --> R
Q --> R
style A fill:#ff8a80,stroke:#d32f2f,color:#000
style L fill:#4fc3f7,stroke:#2196f3,color:#000
style R fill:#81c784,stroke:#4caf50,color:#000
style K fill:#ffab91,stroke:#e64a19,color:#000⚖️ Evidence
⚖️ Evidence Matrix3 supports3 contradicts
Supports
Transglutaminase-2 cross-links tau, α-synuclein, and TDP-43 in disease conditions
Contradicts
TG2 cross-linking often occurs after aggregate formation, not during initial seeding
📖 Linked Papers (9)Export BibTeX ↗
The Search for a Universal Treatment for Defined and Mixed Pathology Neurodegenerative Diseases.
International journal of molecular sciences (2024) · PubMed:39769187 ↗
4 figures

Figure 1
Toxic protein biomarkers shared by specific and mixed pathology NDDs. The references supporting these relationships are cited in the main body of the text. The ...

Figure 2
Calcium–calmodulin mediated signal transduction in normal neurons ( top panel ) and neurodegeneration ( lower panel ). This essential signaling pathway mediates...
[WALANT - Wide Awake Local Anaesthesia No Tourniquet: Complications in elective and acute traumatological Hand Surgery Procedures].
Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V... (2022) · PubMed:35168268 ↗
1 figure
Figures
Figures available at source paper (no open-access XML found).
Successful Nonoperative Treatment of Osteochondritis Dissecans of the Humeral Capitellum in a Young Baseball Player with Advanced Skeletal Maturity.
Progress in rehabilitation medicine (2021) · PubMed:34825100 ↗
4 figures

Fig. 1.
Sonographic image of OCD of the humeral capitellum in the sagittal plane showing irregularity and discontinuity of the subchondral bone.

Fig. 2.
(A) Radiograph taken at the first examination showing an osteochondral lesion on the lateral side of the capitellum and new bone formation along the lateral sid...
Engineering complex communities by directed evolution.
Nature ecology & evolution (2021) · PubMed:33986540 ↗
9 figures

Extended Data Figure 1.
Non-additive function, costly function, and two empirically motivated functions. (A) Illustration of the different types of community function we have considere...

Extended Data Figure 2.
Alternative ecological scenarios with metabolic cross-feeding. Besides the rich medium without cross-feeding shown in the main text, we have included two other ...
Dietary Gluten and Neurodegeneration: A Case for Preclinical Studies.
International journal of molecular sciences (2020) · PubMed:32751379 ↗
3 figures

Figure 1
Occludin (OCLN) protein expression is significantly decreased in duodenal epithelium of celiac macaques. All panels involve triple labels with OCLN ( green ), c...

Figure 2
Immunopathology of central nervous system (CNS) disease in celiac disease patients and potential beneficial (treatment) role of phytocannabinoids as nutraceutic...
TGM2 and implications for human disease: role of alternative splicing.
Front Biosci (Landmark Ed) (2013) · PubMed:23276939 ↗
1 figure
Figures
Figures available at source paper (no open-access XML found).
Calmodulin Binding Domains in Critical Risk Proteins Involved in Neurodegeneration.
Current issues in molecular biology (2022) · PubMed:36421678 ↗
No figures
📙 Related Wiki Pages (15)
EEDgeneNeurodegenerationdiseaseAlibaba Tongyi Qianwen-Bio (Chinese Biomai_toolTGM2 ProteinproteinTGM2 — Transglutaminase 2geneAmyotrophic Lateral SclerosisredirectTau OligomersentityGenesindexEndoplasmic Reticulum Stress and UnfoldemechanismDopaminergic NeuronscellBlood-Brain BarriercellParkinson's DiseasediseaseAmyotrophic Lateral Sclerosis (ALS)diseaseAlzheimer's DiseasediseaseHuntington's Diseasedisease
🏥 Translation
🧬 3D Protein Structure — TGM2
No curated PDB or AlphaFold mapping for TGM2 yet. Search RCSB →
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for TGM2 from GTEx v10.
💉 Clinical Trials (4)Relevance: 13%
2
Active
Active
2
Completed
Completed
0
Total Enrolled
Total Enrolled
Phase II/III
Highest Phase
Highest Phase
Completed·NCT02101957
Completed·NCT03344601
Recruiting·NCT04870866
Recruiting·NCT05538455
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for TGM2.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
💰 Estimated Development
Cost
$0
Timeline
2.0 years
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↘
Falling
7d Momentum
▼ 1.4%
Volatility
Medium
0.0222
Events (7d)
4
Price History
▼24.3%💾 Resource Usage
LLM Tokens
36,356
$0.2181
Total Cost
$0.2181
🔮 Predictions
🔎 Predictions vs Observations3 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| If hypothesis is true, intervention provide non-invasive measures of enzyme activity and inhibitor penetration | provide non-invasive measures of enzyme activity and inhibitor penetration | — no observation — | pending | 0.60 |
| If hypothesis is true, intervention be most beneficial, positioning this strategy for prodromal or mild cognitive impairment stages rather than established dementia | be most beneficial, positioning this strategy for prodromal or mild cognitive impairment stages rather than established dementia | — no observation — | pending | 0.60 |
| If hypothesis is true, intervention enable non-invasive monitoring of enzyme activity in living brains | enable non-invasive monitoring of enzyme activity in living brains | — no observation — | pending | 0.60 |
🔮 Falsifiable Predictions (3)
pendingconf 60%
If hypothesis is true, intervention be most beneficial, positioning this strategy for prodromal or mild cognitive impairment stages rather than established dementia
Predicted outcome: be most beneficial, positioning this strategy for prodromal or mild cognitive impairment stages rather than established dementia
Falsification: Intervention fails to be most beneficial, positioning this strategy for prodromal or mild cognitive impairment stages rather than established dementia
pendingconf 60%
If hypothesis is true, intervention enable non-invasive monitoring of enzyme activity in living brains
Predicted outcome: enable non-invasive monitoring of enzyme activity in living brains
Falsification: Intervention fails to enable non-invasive monitoring of enzyme activity in living brains
pendingconf 60%
If hypothesis is true, intervention provide non-invasive measures of enzyme activity and inhibitor penetration
Predicted outcome: provide non-invasive measures of enzyme activity and inhibitor penetration
Falsification: Intervention fails to provide non-invasive measures of enzyme activity and inhibitor penetration
▸Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
| source | v1_phase_c_backfill |
| origin_type | gap_debate |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.